#BinanceTurns8 Join us in the #BinanceTurns8 celebration and win a share of up to $888,888 in BNB!
24h Vol:
$101.04B
11.76%
Dominance: BTC: 64.5% ETH: 9.2%

CoinMarketCap: Read what our contributors have to say. This content is provided by the community. DYOR!
INJ Gains 46% in 90 Days While Ethereum and Bitcoin Flatten Out
Table of Contents
Market Musing-g
INJ Gains 46% in 90 Days While Ethereum and Bitcoin Flatten Out

By CFU
2 days ago
•
4 mins read

Table of Contents
Daily Activity on Injective Hits 82.5K in Record Surge
Injective Price Holds Firm as Bulls Defend $10 Zone
Q2 Rotation Favored Injective and SUI Among L1 Tokens
Injective surged 46.78% in Q2, while daily active addresses soared 1,500%, confirming rising investor and network traction.
INJ defended the $10 level after spiking to $15 in May, showing strong buyer support and resilient Layer 1 performance.
INJ ranked second behind SUI in L1 gains, with both tokens drawing capital flows while majors like BTC and ETH stayed flat.
Injective (INJ) climbed 46.78% over the past quarter, marking it as the second-best performing Layer 1 protocol. Alongside price gains, Injective's on-chain usage spiked as daily active addresses hit 82,500 in July, confirming significant network momentum.
Daily Activity on Injective Hits 82.5K in Record Surge
Injective has seen a 1,500% spike in daily active addresses since January, reaching 82,500 by early July. In a post by LennaertSnyder, the analyst noted, “Injective is growing exponentially and this is just the beginning,” referencing data from Token Terminal.
Activity remained flat between Q3 2024 and Q1 2025 before rising sharply in mid-March. The metric continued accelerating through Q2, despite a mid-June pullback, signaling consistent protocol usage.
Momentum intensified from April onward, forming a vertical curve into Q3. This parabolic structure confirms Injective’s ongoing traction as network interactions break historical records.
$
